IGM Biosciences CEO Fred Schwarzer's 2020 pay jumps 574% to $5.1M
IGM Biosciences reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
IGM Biosciences reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, three executives at IGM Biosciences received on average a compensation package of $3.4M, a 418% increase compared to previous year.
Average pay of disclosed executives at IGM Biosciences
Fred Schwarzer, Chief Executive Officer, received $5.1M in total, which increased by 574% compared to 2019. 83% of Schwarzer's compensation, or $4.3M, was in option awards. Schwarzer also received $318K in non-equity incentive plan and $530K in salary.
Bruce Keyt, Chief Scientific Officer, received a compensation package of $2.8M, which increased by 359% compared to previous year. 77% of the compensation package, or $2.1M, was in option awards.
Daniel S. Chen, Chief Medical Officer, earned $2.2M in 2020.
Related executives
You may also like
Source: SEC filing on April 29, 2021.